【Analysis: The highest floating profit for BIO private placement participants has reached 92 times, while the lowest floating profit for public offerings is nearly 15 times】According to a report by Jinse Finance, analysis by ai_9684xtpa states that BIO Protocol has raised $30.2 million in funding: there were two rounds of private placements, raising a total of $2.3 million, with valuations of $35 million and $69 million respectively; there were three rounds of public offerings (namely BIO Genesis auction), raising a total of $27.9 million, with valuations of $85 million / $142 million / $219 million in the three rounds. Currently, BIO has been launched for pre-trading on Bybit and Bitget, with a pre-trading average price of $0.9659 calculated at 22:00 on 12.29 across the two platforms, resulting in a BIO FDV of approximately $3.2 billion. Private placement investors: account for 13.60% of the total supply; public offering investors: account for 20.00% of the total supply. The costs are as follows: Private placement · Pre-seed round: cost approximately $0.01054, current floating profit 91.62 times; · During seed round: cost approximately $0.02078, current floating profit 46.48 times; Public offering · Round 1: cost approximately $0.0256, current floating profit 37.73 times; · Round 2: cost approximately $0.04277, current floating profit 22.58 times; · Round 3: cost approximately $0.06596, current floating profit 14.64 times.